+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease



Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease



Neurobiology of Aging 34(6): 1653-1661



Synapses are essential for transmitting, processing, and storing information, all of which decline in aging and Alzheimer's disease (AD). Because synapse loss only partially accounts for the cognitive declines seen in aging and AD, we hypothesized that existing synapses might undergo molecular changes that reduce their functional capacity. Microarrays were used to evaluate expression profiles of 340 synaptic genes in aging (20-99 years) and AD across 4 brain regions from 81 cases. The analysis revealed an unexpectedly large number of significant expression changes in synapse-related genes in aging, with many undergoing progressive downregulation across aging and AD. Functional classification of the genes showing altered expression revealed that multiple aspects of synaptic function are affected, notably synaptic vesicle trafficking and release, neurotransmitter receptors and receptor trafficking, postsynaptic density scaffolding, cell adhesion regulating synaptic stability, and neuromodulatory systems. The widespread declines in synaptic gene expression in normal aging suggests that function of existing synapses might be impaired, and that a common set of synaptic genes are vulnerable to change in aging and AD.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036807064

Download citation: RISBibTeXText

PMID: 23273601

DOI: 10.1016/j.neurobiolaging.2012.11.024


Related references

Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 58(6): 637-643, 1999

Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology 52(9): 1861-1870, 1999

Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer's disease. Acta Neuropathologica 137(4): 557-569, 2019

Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging. Neuroimage 49(1): 169-176, 2010

Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease. Journal of Alzheimer's Disease 56(3): 1119-1126, 2017

Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process?. Ajnr. American Journal of Neuroradiology 22(9): 1680-1685, 2001

Characterization of the human brain microtubule system in normal aging and alzheimer disease. FASEB Journal 6(5): A1917, 1992

Impairment of G(salpha) function in human brain cortex of Alzheimer's disease: comparison with normal aging. Journal of Neural Transmission 111(3): 311-322, 2004

Functional brain network subtypes are associated with Alzheimer's disease biomarkers in an aging, high-risk, cognitively normal cohort: The prevent-alzheimer's disease study. Alzheimer's & Dementia 11(7): P239-P240, 2015

Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder. Biochimica et Biophysica Acta 1862(6): 1084-1092, 2016

Biochemical aspects on normal aging and Alzheimer's disease. The aging of the brain. Nordisk Medicin 101(4): 108, 1986

Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration. Dementia 7(3): 128-134, 1996

Cholesterol and synaptic compensatory mechanisms in Alzheimer's disease mice brain during aging. Journal of Alzheimer's Disease 31(4): 813-826, 2012

The human homolog of the QKI gene affected in the severe dysmyelination quaking mouse phenotype: Downregulated in multiple brain regions in schizophrenia. American Journal of Psychiatry 163(10): 1834-1837, 2006

Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients. Journal of Molecular Neuroscience 8(2): 75-82, 1997